ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

IFRX InflaRx NV

1.46
-0.05 (-3.31%)
2024年6月19日 - 終了
15分遅延
名称 銘柄コード 市場 種別
InflaRx NV IFRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.05 -3.31% 1.46 09:00:00
始値 安値 高値 終値 前日終値
1.50 1.45 1.50 1.46 1.51
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0606:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0601:00GLOBEInflaRx Hosts R&D Event Highlighting the Promise of INF904
2024/5/2205:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2203:30GLOBEInflaRx Presents New Analysis of PANAMO Phase III Trial in..
2024/5/0821:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0820:30GLOBEInflaRx Reports First Quarter 2024 Financial Results and..
2024/4/3020:30GLOBEInflaRx to Host Virtual R&D Event on June 5, 2024 and..
2024/4/2420:30GLOBEInflaRx to Participate in Capital One Securities 1st Annual..
2024/3/2120:00GLOBEInflaRx Reports Full Year 2023 Results and Announces INF904..
2024/3/1920:30GLOBEInflaRx to Announce Development Plans for INF904 and 2023..
2024/2/2221:30GLOBEInflaRx Appoints Jan Medina as Head of Investor Relations
2024/1/2522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2521:30GLOBEInflaRx Announces Initiation of its Commitment Program for..
2024/1/0506:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0421:00GLOBEInflaRx Announces Positive Topline Results from the Multiple..
2023/11/0622:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0621:30GLOBEInflaRx Announces First Patient Dosed in Phase III Trial..
2023/11/0121:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0120:30GLOBEInflaRx Reports Third Quarter 2023 Financial Results and..
2023/9/1121:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1120:00GLOBEInflaRx Announces Positive Topline Results from the Single..
2023/8/3021:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/3020:30GLOBEInflaRx’s Marketing Authorization Application (MAA) for..
2023/8/1021:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1020:30GLOBEInflaRx Reports Second Quarter 2023 Financial Results &..
2023/7/1305:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/1213:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/7/0105:06EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/6/2821:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/6/2820:30GLOBEInflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
2023/6/2120:00GLOBEInflaRx Announces Commercial Launch of Gohibic (vilobelimab)..

最近閲覧した銘柄

Delayed Upgrade Clock